Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | CTSG | P08311 | 1/20 | 0.33 |
| ▸ | CYSLTR2 | Q9NS75 | 5/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 5/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17847443 | 0.90 | GABRA1 (0.44) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL29651833 | 0.87 | CYP3A4 (0.51) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL993745 | 0.87 | CYP3A4 (0.51) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL10435889 | 0.85 | GABRA1 (0.53) | CYP3A4CYP2D6GABRA1GABRB2PPARA | |
| SCHEMBL2350176 | 0.82 | CYP3A4 (0.46) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885474 | 0.81 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885360 | 0.81 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL10400982 | 0.81 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885574 | 0.81 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5884676 | 0.81 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233791-B1 | MOISTURE STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2020-08-12 | — | — | EP | disclosed |
| US-10329244-B2 | Moisture-stable holographic media | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
| EP-3233791-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | Covestro Deutschland AG (DE) | 2017-10-25 | — | — | EP | disclosed |
| CN-107223121-A | Wet stable holographic media | 科思创德国股份有限公司 | 2017-09-29 | — | — | CN | disclosed |
| WO-2016096641-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329244-B2 | Moisture-stable holographic media | NEFM, MDM4, BHMT2 | CYP3A4 3992/4885CYP2D6 2666/4885CYP2C9 4043/4885 |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | NEFM, MDM4, BHMT2 | CYP3A4 3992/4885CYP2D6 2666/4885CYP2C9 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.